Literature DB >> 32178529

Interest in HIV pre-exposure prophylaxis (PrEP) among adolescents and their caregivers in Malawi.

Rachel Kidman1, Sharon Nachman2, Hans-Peter Kohler3.   

Abstract

Over a third of new HIV infections occur in adolescents aged 10-19 globally. Pre-exposure prophylaxis (PrEP) could be a powerful tool for prevention. Understanding more about the drivers of PrEP interest could inform implementation strategies among this age group. Moreover, family dynamics may play a uniquely critical role for this younger age group, thus it is important to gauge whether caregivers would support their children's use of PrEP. We surveyed 2,089 adolescents (aged 10-16) and their caregivers in Malawi during 2017-2018. Data were collected on PrEP interest, factors that may facilitate PrEP use, and preferences for PrEP modality. We used multivariate logistic regression to estimate the association between the above characteristics and PrEP interest. We find that young adolescents are engaging in behaviors that would put them at substantial risk of acquiring HIV, would likely benefit from PrEP, are largely (82%) interested in using such, would prefer to get an injection over taking a daily pill, and are considerably discouraged by the prospect of side effects. Endorsement by caregivers was even greater (87%). Our findings demonstrate initial support for adolescent PrEP, and suggest parents may be a surprising advocate.

Entities:  

Keywords:  HIV; Malawi; adolescent; pre-exposure prophylaxis

Mesh:

Substances:

Year:  2020        PMID: 32178529      PMCID: PMC8073398          DOI: 10.1080/09540121.2020.1742861

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  32 in total

1.  PrEP introduction for adolescent girls and young women.

Authors:  Sanyukta Mathur; Nanlesta Pilgrim; Julie Pulerwitz
Journal:  Lancet HIV       Date:  2016-09       Impact factor: 12.767

2.  Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.

Authors:  Jean B Nachega; Michael Hislop; Hoang Nguyen; David W Dowdy; Richard E Chaisson; Leon Regensberg; Mark Cotton; Gary Maartens
Journal:  J Acquir Immune Defic Syndr       Date:  2009-05-01       Impact factor: 3.731

Review 3.  Pre-exposure prophylaxis for South African adolescents: What evidence?

Authors:  L-G Bekker; K Gill; M Wallace
Journal:  S Afr Med J       Date:  2015-11

4.  Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial.

Authors:  Amy Corneli; Brian Perry; Kevin McKenna; Kawango Agot; Khatija Ahmed; Jamilah Taylor; Fulufhelo Malamatsho; Jacob Odhiambo; Joseph Skhosana; Lut Van Damme
Journal:  J Acquir Immune Defic Syndr       Date:  2016-04-01       Impact factor: 3.731

5.  High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.

Authors:  Elisabeth Maria Van der Elst; Judie Mbogua; Don Operario; Gaudensia Mutua; Caroline Kuo; Peter Mugo; Jennifer Kanungi; Sagri Singh; Jessica Haberer; Frances Priddy; Eduard Joachim Sanders
Journal:  AIDS Behav       Date:  2013-07

Review 6.  Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Siyan Yi; Sovannary Tuot; Grace W Mwai; Chanrith Ngin; Kolab Chhim; Khoundyla Pal; Ewemade Igbinedion; Paula Holland; Sok Chamreun Choub; Gitau Mburu
Journal:  J Int AIDS Soc       Date:  2017-06-26       Impact factor: 5.396

Review 7.  Values and Preferences on the Use of Oral Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Multiple Populations: A Systematic Review of the Literature.

Authors:  Florence M Koechlin; Virginia A Fonner; Sarah L Dalglish; Kevin R O'Reilly; Rachel Baggaley; Robert M Grant; Michelle Rodolph; Ioannis Hodges-Mameletzis; Caitlin E Kennedy
Journal:  AIDS Behav       Date:  2017-05

Review 8.  HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.

Authors:  Connie L Celum; Sinead Delany-Moretlwe; Jared M Baeten; Ariane van der Straten; Sybil Hosek; Elizabeth A Bukusi; Margaret McConnell; Ruanne V Barnabas; Linda-Gail Bekker
Journal:  J Int AIDS Soc       Date:  2019-07       Impact factor: 5.396

9.  A descriptive analysis of perceptions of HIV risk and worry about acquiring HIV among FEM-PrEP participants who seroconverted in Bondo, Kenya, and Pretoria, South Africa.

Authors:  Amy L Corneli; Kevin McKenna; Jennifer Headley; Khatija Ahmed; Jacob Odhiambo; Joseph Skhosana; Meng Wang; Kawango Agot
Journal:  J Int AIDS Soc       Date:  2014-09-08       Impact factor: 5.396

10.  The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study.

Authors:  Natasha Mack; Emily M Evens; Elizabeth E Tolley; Kate Brelsford; Caroline Mackenzie; Cecilia Milford; Jennifer A Smit; Joshua Kimani
Journal:  J Int AIDS Soc       Date:  2014-09-08       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.